Iris Nederlof (I Nederlof)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Estrogen Receptor

Chemotherapy Induced

Endoplasmic Reticulum Stress

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ breast cancer

Nature medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Iris Nederlof, Olga I Isaeva, Manon de Graaf, Robbert C A M Gielen, Noor A M Bakker, Adrianne L Rolfes, Hannah Garner, Bram Boeckx, Joleen J H Traets, Ingrid A M Mandjes, Michiel de Maaker, Thomas van Brussel, Maksim A Chelushkin, Elisa Champanhet, Marta Lopez-Yurda, Koen K van de Vijver, José G van den Berg, Ingrid Hofland, Natasja Klioueva, Ritse M Mann, Claudette E Loo, Frederieke H van Duijnhoven, Victoria Skinner, Sylvia Luykx, Emile Kerver, Ekaterina Kalashnikova, Marloes G J van Dongen, Gabe S Sonke, Sabine C Linn, Christian U Blank, Karin E de Visser, Roberto Salgado, Lodewyk F A Wessels, Caroline A Drukker, Ton N M Schumacher, Hugo Mark Horlings, Diether Lambrechts, Marleen Kok
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial. Nature medicine (2024)
Iris Nederlof, Leonie Voorwerk, Marleen Kok
Facts and hopes in immunotherapy for early-stage triple-negative breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lennart Kester, Danielle Seinstra, Annelot G J van Rossum, Claire Vennin, Marlous Hoogstraat, Daphne L van der Velden, Mark Opdam, Erik D van Werkhoven, Kerstin Hahn, Iris Nederlof, Ester H Lips, Ingrid A M Mandjes, A Elise van Leeuwen-Stok, Sander Canisius, Harm D R van Tinteren, Alex L T Imholz, Johanneke E A Portielje, Monique E M M Bos, Sandra D Bakker, Emiel J T Rutgers, Hugo Mark Horlings, Jelle Wesseling, Emile E Voest, Lodewyk F A Wessels, Marleen Kok, Hendrika M Oosterkamp, Alexander van Oudenaarden, Sabine C Linn, Jacco van Rheenen
Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (5) (2022)
Iris Nederlof, S Hajizadeh, Faranak Sobhani, Shan E Ahmed Raza, Khalid AbdulJabbar, R Harkes, M J van de Vijver, Roberto Salgado, Christine Desmedt, M Kok, Y Yuan, Hugo Mark Horlings
Spatial interplay of lymphocytes and fibroblasts in estrogen receptor-positive HER2-negative breast cancer. NPJ breast cancer 8 (1) (2022)
Dora Hammerl, John W M Martens, Mieke Timmermans, Marcel Smid, Anita M Trapman-Jansen, Renée Foekens, Olga I Isaeva, Leonie Voorwerk, Hayri E Balcioglu, Rebecca Wijers, Iris Nederlof, Roberto Salgado, Hugo Mark Horlings, Marleen Kok, Reno Debets
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer. Nature communications 12 (1) (2021)